Gut microbiota and blood biomarkers in IBD-Related arthritis: insights from mendelian randomization

Abstract With the ongoing rise in the incidence of inflammatory bowel disease (IBD), its extraintestinal manifestations have garnered significant attention. IBD-related arthritis is notable for its insidious onset and unpredictability, presenting considerable challenges for clinical diagnosis and ma...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei Yang, Miao Cui, Peng Yang, Chenlin Liu, Xiuzhen Han, Wenyi Yao, Zhenhua Li
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-84116-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559645850697728
author Wei Yang
Miao Cui
Peng Yang
Chenlin Liu
Xiuzhen Han
Wenyi Yao
Zhenhua Li
author_facet Wei Yang
Miao Cui
Peng Yang
Chenlin Liu
Xiuzhen Han
Wenyi Yao
Zhenhua Li
author_sort Wei Yang
collection DOAJ
description Abstract With the ongoing rise in the incidence of inflammatory bowel disease (IBD), its extraintestinal manifestations have garnered significant attention. IBD-related arthritis is notable for its insidious onset and unpredictability, presenting considerable challenges for clinical diagnosis and management. Factors such as gut microbiota, plasma proteins, inflammatory proteins, and biomarkers found in blood and urine may be closely associated with IBD-related arthritis. However, the mechanisms by which these factors influence this condition remain poorly understood and require urgent investigation. We employed the method of linkage disequilibrium and the two-sample Mendelian randomization (MR) approach, utilizing single nucleotide polymorphisms (SNPs) identified from large-scale genome-wide association studies as instrumental variables. In this scientifically rigorous manner, we explored the potential causal relationship between gut microbiota, plasma proteins, inflammatory proteins, and blood and urine biomarkers in relation to arthritis resulting from inflammatory bowel disease (IBD). This method aids in elucidating the potential roles of these biomarkers in the development of arthritis following IBD, while minimizing the confounding factors and reverse causality commonly encountered in observational studies. To further verify and strengthen our findings, we conducted subsequent sensitivity analyses. These analyses will evaluate the strength of the association between SNPs and the studied biomarkers, as well as post-IBD arthritis, while accounting for variations in SNP distribution among populations and other potential genetic influencing factors. Through these rigorous analytical steps, our objective is to enhance the robustness and credibility of the research findings and provide more reliable scientific evidence regarding the pathogenesis of post-IBD arthritis. MR analysis provides evidence for the association between genetically predicted gut microbiota, plasma proteins, inflammatory proteins, and blood and urine biomarkers with the risk of IBD-related arthritis. This analysis investigates the characteristics of the associations between specific gut microbiota, plasma proteins, inflammatory proteins, and blood and urine biomarkers in relation to IBD-related arthritis. Among the plasma proteins, pterin-4-alpha-carbinolamine dehydratase, aldo-keto reductase family 1 member C4, cathepsin L2, angiostatin, hepatocyte growth factor-like protein, hepatitis A virus cellular receptor 2, protein O-linked mannose beta-1,4-N-acetylglucosaminyltransferase 2, epididymal-specific alpha-mannosidase, and platelet-derived growth factor receptor-like protein are associated with Crohn’s disease-related arthritis. In contrast, agrin, methylenetetrahydrofolate synthetase domain-containing protein, neurotrophin-3 (NT-3) growth factor receptor, and neuropilin-1 are associated with ulcerative colitis-related arthritis. Furthermore, regarding gut bacterial pathway abundance, adenosylcobalamin, N-acetylglucosamine, N-acetylmannosamine, and N-acetylneuraminic acid degradation, as well as glycolysis metabolism and degradation pathways, are associated with Crohn’s disease-related arthritis. Meanwhile, gut bacterial pathway abundance (pentose phosphate pathway) and gut microbiota abundance (Bacteroidetes, Bacteroidia, Bacteroidales, Porphyromonadaceae, Faecalibacterium, Eubacterium eligens) are linked to ulcerative colitis-related arthritis. Notably, we did not identify any connections between inflammatory protein factors, blood and urine biomarkers, and IBD-related arthritis. Lastly, in the reverse MR study, the insufficient number of SNPs available for analysis precluded the detection of a reverse causal relationship. This study employs the MR method to elucidate the potential causal relationships among gut microbiota, plasma proteins, inflammatory proteins, and blood and urine biomarkers in relation to the occurrence and progression of IBD-related arthritis. This research offers a novel perspective for a deeper understanding of the pathogenesis of IBD-related arthritis and highlights future directions for the diagnosis and treatment strategies of this condition.
format Article
id doaj-art-281da28c2fde463b9994c7490f99c591
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-281da28c2fde463b9994c7490f99c5912025-01-05T12:19:13ZengNature PortfolioScientific Reports2045-23222025-01-0115112310.1038/s41598-024-84116-6Gut microbiota and blood biomarkers in IBD-Related arthritis: insights from mendelian randomizationWei Yang0Miao Cui1Peng Yang2 Chenlin Liu3Xiuzhen Han4Wenyi Yao5Zhenhua Li6Changchun University of Chinese MedicineSchool of Traditional Chinese Medicine, Capital Medical UniversitySouth China Normal UniversityChangchun University of Chinese MedicineJiangsu Province Hospital of Traditional Chinese MedicineThe Seventh Affiliated Hospital of Shanghai University of Traditional Chinese MedicineChangchun University of Chinese MedicineAbstract With the ongoing rise in the incidence of inflammatory bowel disease (IBD), its extraintestinal manifestations have garnered significant attention. IBD-related arthritis is notable for its insidious onset and unpredictability, presenting considerable challenges for clinical diagnosis and management. Factors such as gut microbiota, plasma proteins, inflammatory proteins, and biomarkers found in blood and urine may be closely associated with IBD-related arthritis. However, the mechanisms by which these factors influence this condition remain poorly understood and require urgent investigation. We employed the method of linkage disequilibrium and the two-sample Mendelian randomization (MR) approach, utilizing single nucleotide polymorphisms (SNPs) identified from large-scale genome-wide association studies as instrumental variables. In this scientifically rigorous manner, we explored the potential causal relationship between gut microbiota, plasma proteins, inflammatory proteins, and blood and urine biomarkers in relation to arthritis resulting from inflammatory bowel disease (IBD). This method aids in elucidating the potential roles of these biomarkers in the development of arthritis following IBD, while minimizing the confounding factors and reverse causality commonly encountered in observational studies. To further verify and strengthen our findings, we conducted subsequent sensitivity analyses. These analyses will evaluate the strength of the association between SNPs and the studied biomarkers, as well as post-IBD arthritis, while accounting for variations in SNP distribution among populations and other potential genetic influencing factors. Through these rigorous analytical steps, our objective is to enhance the robustness and credibility of the research findings and provide more reliable scientific evidence regarding the pathogenesis of post-IBD arthritis. MR analysis provides evidence for the association between genetically predicted gut microbiota, plasma proteins, inflammatory proteins, and blood and urine biomarkers with the risk of IBD-related arthritis. This analysis investigates the characteristics of the associations between specific gut microbiota, plasma proteins, inflammatory proteins, and blood and urine biomarkers in relation to IBD-related arthritis. Among the plasma proteins, pterin-4-alpha-carbinolamine dehydratase, aldo-keto reductase family 1 member C4, cathepsin L2, angiostatin, hepatocyte growth factor-like protein, hepatitis A virus cellular receptor 2, protein O-linked mannose beta-1,4-N-acetylglucosaminyltransferase 2, epididymal-specific alpha-mannosidase, and platelet-derived growth factor receptor-like protein are associated with Crohn’s disease-related arthritis. In contrast, agrin, methylenetetrahydrofolate synthetase domain-containing protein, neurotrophin-3 (NT-3) growth factor receptor, and neuropilin-1 are associated with ulcerative colitis-related arthritis. Furthermore, regarding gut bacterial pathway abundance, adenosylcobalamin, N-acetylglucosamine, N-acetylmannosamine, and N-acetylneuraminic acid degradation, as well as glycolysis metabolism and degradation pathways, are associated with Crohn’s disease-related arthritis. Meanwhile, gut bacterial pathway abundance (pentose phosphate pathway) and gut microbiota abundance (Bacteroidetes, Bacteroidia, Bacteroidales, Porphyromonadaceae, Faecalibacterium, Eubacterium eligens) are linked to ulcerative colitis-related arthritis. Notably, we did not identify any connections between inflammatory protein factors, blood and urine biomarkers, and IBD-related arthritis. Lastly, in the reverse MR study, the insufficient number of SNPs available for analysis precluded the detection of a reverse causal relationship. This study employs the MR method to elucidate the potential causal relationships among gut microbiota, plasma proteins, inflammatory proteins, and blood and urine biomarkers in relation to the occurrence and progression of IBD-related arthritis. This research offers a novel perspective for a deeper understanding of the pathogenesis of IBD-related arthritis and highlights future directions for the diagnosis and treatment strategies of this condition.https://doi.org/10.1038/s41598-024-84116-6Gut microbiotaPlasma proteinsInflammatory proteinsBlood and urine biomarkersIBD-related arthritisMendelian randomization
spellingShingle Wei Yang
Miao Cui
Peng Yang
Chenlin Liu
Xiuzhen Han
Wenyi Yao
Zhenhua Li
Gut microbiota and blood biomarkers in IBD-Related arthritis: insights from mendelian randomization
Scientific Reports
Gut microbiota
Plasma proteins
Inflammatory proteins
Blood and urine biomarkers
IBD-related arthritis
Mendelian randomization
title Gut microbiota and blood biomarkers in IBD-Related arthritis: insights from mendelian randomization
title_full Gut microbiota and blood biomarkers in IBD-Related arthritis: insights from mendelian randomization
title_fullStr Gut microbiota and blood biomarkers in IBD-Related arthritis: insights from mendelian randomization
title_full_unstemmed Gut microbiota and blood biomarkers in IBD-Related arthritis: insights from mendelian randomization
title_short Gut microbiota and blood biomarkers in IBD-Related arthritis: insights from mendelian randomization
title_sort gut microbiota and blood biomarkers in ibd related arthritis insights from mendelian randomization
topic Gut microbiota
Plasma proteins
Inflammatory proteins
Blood and urine biomarkers
IBD-related arthritis
Mendelian randomization
url https://doi.org/10.1038/s41598-024-84116-6
work_keys_str_mv AT weiyang gutmicrobiotaandbloodbiomarkersinibdrelatedarthritisinsightsfrommendelianrandomization
AT miaocui gutmicrobiotaandbloodbiomarkersinibdrelatedarthritisinsightsfrommendelianrandomization
AT pengyang gutmicrobiotaandbloodbiomarkersinibdrelatedarthritisinsightsfrommendelianrandomization
AT chenlinliu gutmicrobiotaandbloodbiomarkersinibdrelatedarthritisinsightsfrommendelianrandomization
AT xiuzhenhan gutmicrobiotaandbloodbiomarkersinibdrelatedarthritisinsightsfrommendelianrandomization
AT wenyiyao gutmicrobiotaandbloodbiomarkersinibdrelatedarthritisinsightsfrommendelianrandomization
AT zhenhuali gutmicrobiotaandbloodbiomarkersinibdrelatedarthritisinsightsfrommendelianrandomization